INTRODUCTION
============

Before a cell divides it must first faithfully copy its DNA so that each daughter cell receives a full complement of genetic information. In the eukaryotic cell cycle chromosomal duplication is restricted to S phase, and chromosomal segregation to M phase, with these phases separated by the gap phases G1 and G2 ([@B1]). Checkpoints are important for controlling these events, delaying the cell cycle in response to incomplete DNA replication or DNA damage ([@B2],[@B3]), and are essential for the maintenance of genomic integrity and to prevent ploidy changes. Failure to arrest the cell cycle in these situations contributes to cancer development and may cause resistance to standard treatments ([@B3]).

The mitotic cell cycle and checkpoint controls of the fission yeast *Schizosaccharomyces pombe* resemble those of higher organisms with distinct G1-S-G2-M phases and with mammalian homologues identified for the major fission yeast checkpoint genes ([@B4; @B5; @B6; @B7]). Activation of the cyclin dependent kinase Cdc2 is required for entry into mitosis, and inhibitory phosphorylation on tyrosine 15 by Wee1 and Mik1 maintains the Cdc2-cyclin complex in an inactive state until dephosphorylation occurs through Cdc25 ([@B8]). Six genes have been identified that are involved in activating the checkpoint response by an S phase block (the S-M checkpoint) or DNA damage, that are collectively referred to as the checkpoint *rad* genes (*rad1, 3, 9, 17, 26 and hus1*) ([@B8; @B9; @B10; @B11; @B12; @B13]). Cells mutated in these genes are hypersensitive to DNA damage and to hydroxyurea (HU), an inhibitor of DNA replication ([@B9],[@B11]). Rad3 phosphorylates and activates the Cds1 kinase after a DNA replication block, and also phosphorylates and activates the Chk1 kinase after DNA damage, although Chk1 can substitute for Cds1 in a DNA replication block ([@B14],[@B15]). Checkpoint activation blocks mitotic onset by decreasing the activity of the mitotic Cdc2/cyclin complexes as a consequence of Cdc2 tyrosine 15 phosphorylation. Cds1 also plays a role in recovery from the S phase arrest, and in an HU-induced S phase block cells lacking Cds1 lose viability ([@B14],[@B16; @B17; @B18; @B19; @B20]).

Both Chk1 and Cds1 phosphorylation and activation are dependent on the presence of Rad3 and other checkpoint Rad proteins ([@B21]). However, the sequence of upstream events leading to activation of Rad3 is unclear with the identity of the DNA damage/incomplete replication sensors and initial checkpoint activators remaining uncertain. One possibility is replication protein A (RPA) coated single-stranded DNA (ssDNA), which is a common structure generated at sites of DNA damage and is thought to play a role in recruiting two key complexes to damaged DNA: the human ATR ([AT]{.ul}M- and [R]{.ul}ad3-related) protein complexed with its regulatory partner ATRIP, and the Rad17 complex ([@B22],[@B23]). We set out to find new genes or a new role for known genes involved in checkpoint activation upstream of Rad3. We postulated that overexpression of such genes would ectopically activate the replication and/or damage checkpoint. In the presence of Rad3 this would activate the checkpoint and arrest the cell cycle, but in its absence cells would grow and divide normally. In this study we show that increased levels or stabilization of Cdc18/CDC6, a key factor initiating DNA replication in eukaryotes, induce a Rad3-dependent checkpoint response in the apparent absence of DNA replication structures, and we investigate how this system operates.

MATERIALS AND METHODS
=====================

Yeast strains and methods
-------------------------

All experiments were carried out in EMM2 minimal media unless otherwise stated. Growth conditions and DAPI staining are as described previously ([@B24]). The mutant strain *cdc25-22* ([@B25]) growing exponentially at 25°C was shifted to 36°C to arrest cells in late G2. The *rad3^ts^* and *rad3*Δ strains were a gift from Tony Carr, and the *rad22*Δ strain was constructed for this study. The *gar2-GFP* and *rqh1*Δ were a gift from Shao-Win Wang. The *reb1*Δ was a gift from Pablo Hernandez. Thiamine-regulatable *nmt1* promoters ([@B26],[@B27]) were repressed using 5 μg/ml of thiamine. Hydroxyurea (HU) was used at 12 mM. Flow cytometry analysis were performed on a Becton--Dickinson FACScan using propidium iodine staining of fixed cells as described previously ([@B28]). Deletion and genomic tagging were done as described previously ([@B29],[@B30]). [Table 1](#T1){ref-type="table"} lists the *cdc18-T6A*-containing strains constructed for this study. Table 1.*Cdc18-T6A*-containing and control strains used in this study. CCL stands for [C]{.ul}ell [C]{.ul}ycle [L]{.ul}aboratory. CCL3 was a gift from Tony Carr. CCL2, CCL4-5 and CCL7-26 were constructed for this study. CCL1 and CCL6 had been previously constructedStrainsCCL*h− ade6-704 leu1-32 ura4-D18*1*h+/h− rad3^ts^/rad3^ts^ cdc18Δ::ura4^+^/cdc18^+^ ade6-M210/ade6-M216 ura4-D18/ura4-D18*2*h− rad3^ts^ ade6-704 leu1-32 ura4-D18*3*rad3^ts^ ade6-704 leu1-32*4*reb1Δ::kan^r^ rad3^ts^ cdc18-T6A*5*h− rad3-136 leu1-32 ura4-D18*6*h+ cdc25-22^ts^ rad3Δ::ura4^+^ leu1-32 ura4-D18*7*h+ cdc25-22^ts^ rad3Δ::ura4^+^ cdc18-TAP-kan^r^ leu1-32 ura4-D18*8*h+ rad3^ts^ cdc18-T6A ade6-M210 ura4-D18*9*h+ rad3^ts^ cdc18-T6A ade6-M210*10*rad22Δ::kan^r^ rad3^ts^ cdc18-T6A*11*h+ rad3^ts^ cdc18-T6A chk1-HA ade6-M210 ura4-D18*12*h+ cdc25-22^ts^ rad3Δ::ura4^+^ cdc18-T6A-TAP-kan^r^ leu1-32 ura4-D18*13*h+ rad3Δ::ura4^+^ cdc18-T6A ura4-D18*14*chk1Δ::kan^r^ rad3^ts^ cdc18-T6A ura4-D18*15*cds1Δ::kan^r^ rad3^ts^ cdc18-T6A ura4-D18*16*chk1Δ::kan^r^ cds1Δ::ura4^+^ rad3^ts^ cdc18-T6A ura4-D18*17*mrc1Δ::kan^r^ rad3^ts^ cdc18-T6A ura4-D18*18*crb2Δ::kan^r^ rad3^ts^ cdc18-T6A ura4-D18*19*rad9Δ::kan^r^ rad3^ts^ cdc18-T6A ura4-D18*20*rad1Δ::kan^r^ rad3^ts^ cdc18-T6A ura4-D18*21*rad17Δ::kan^r^ rad3^ts^ cdc18-T6A ura4-D18*22*rad26Δ::kan^r^ rad3^ts^ cdc18-T6A ura4-D18*23*hus1Δ::kan^r^ rad3^ts^ cdc18-T6A ura4-D18*24*gar2-GFP rad3^ts^ cdc18-T6A*25*gar2-GFP rad3^ts^*26

cDNA library screen
-------------------

A Gateway compatible Lifetech library was constructed from total *S. pombe* RNA derived from mitotic, meiotic and shmooing cells in a 2:1:1 ratio, within a Gateway modified version of the ura4 based pRep4X vector (T. Duhig personal communication). The library was transformed into *h* *+* *rad3^ts^ leu1-32 ura4-D18 ade6-704* (CCL3) using the modified Lithium Acetate protocol ([@B27]) ([Figure 1](#F1){ref-type="fig"}A). Briefly, the transformed cells were plated out and left to grow for 5 days at 25°C under selective conditions in the presence of 15 µM thiamine to suppress gene expression. They were then replica-plated onto selective media, containing Phloxin B (to aid identification of sick elongated cells), at 25 and 36°C in the absence of thiamine to allow expression of the gene controlled by the *nmt1* promoter. After 24 h, 80 000 colonies were screened to identify colonies showing elongation at 25°C and normal growth at 36°C. Eight colonies were identified and plasmids containing *cdc18, tel1, MCM7*, and *sty1* were recovered, suggesting Rad3-dependent checkpoint roles for these genes. Figure 1.Overexpression of Cdc18 induces a Rad3-dependent cell cycle arrest with no evidence of re-replication. (**A**) Schematic of the screen. (**B**) *Rad3^ts^* cells containing pRep4X *cdc18* were grown on selective media plus thiamine (OFF) for 5 days at 25°C and then replica-plated onto selective media without thiamine (ON) at 25 and 36°C. Left panel: microscopy after 24 h at 25°C. Right panel: microscopy after 24 h at 36°C. (**C**) A culture of *rad3^ts^* cells containing pRep4X *cdc18* was grown for 24 h in selective media plus thiamine (OFF) before resuspension of cells in selective media minus thiamine for 11 h (ON). Half the culture remained at 25°C, the other half shifted to 36°C, for 8 h. Samples were taken every 2 h for microscopy and FACS analysis. Left panel: 25°C with no re-replication. Right panel: 36°C with no re-replication. (**D**) A re-replicating control strain (*rad3+* pRep3X *cdc18*) was grown for 24 h at 32°C in selective media plus thiamine (OFF) before resuspension of cells in selective media minus thiamine for 11 h (ON). Samples were taken every 2 h for FACS analysis. Note the increasing DNA content with time.

Generation and integration of the Cdc18 phosphorylation mutant
--------------------------------------------------------------

A PCR fragment of the *cdc18* gene encoding the mutant protein (with six threonine residues mutated to alanine, at positions 10, 46, 60, 104, 134 and 374) was used to replace the endogenous *cdc18+* gene. The PCR reaction was performed using a plasmid containing the mutant as template and covered the entire open reading frame plus an additional 114 bp upstream and 367 bp downstream ([@B31]). The 2300 bp PCR product was purified and transformed into a homozygous *rad3^ts^* diploid strain (CCL2) where one copy of the *cdc18* open reading frame was replaced by *ura4^+^* ([@B32]). Cells were replica-plated on rich medium containing 5-FOA after overnight incubation on rich medium without selection. Clones with successful recombination at the *cdc18* locus were screened for by PCR and the diploid sporulated to generate haploid *rad3^ts^ cdc18-T6A* mutants. It should be noted that this strain could not be constructed in a *rad3^+^* background.

The *cdc18* gene is linked to the *leu1* gene, so the *cdc18-T6A* mutation here is linked to *leu1^+^*. In subsequent crosses this linkage was exploited to select for the *cdc18-T6A* mutation, which was then confirmed by PCR. The *cdc18-T6A* gene was also TAP tagged by gene targeting at the locus as described previously ([@B29],[@B30]). In this case G418 resistance was used to follow the *cdc18-T6A* mutation.

Biochemical analysis
--------------------

For western blotting cells were boiled for 6 min after being washed once in STOP buffer (150 mM NaCl, 50 mM NaF, 1 mM NaN~3~, 10 mM EDTA pH 8.0). Protein extracts were prepared using glass beads in HB ([@B24]) and a fastprep machine (Bio101). Protein concentration was determined using the BCA kit from Sigma. About 50 μg was separated on 10% SDS-PAGE and blotted on nitrocellulose membrane (Amersham Hybond ECL) and detected by ECL (Amersham). The antibodies used were PAP (Sigma) at 1:1000, monoclonal anti-HA (Babco) at 1:1000 and polyclonal anti-Cdc18 antibodies ([@B33]) at 1:1000.

Neutral--neutral 2D-gels electrophoresis
----------------------------------------

Approximately 8 × 10^8^ cells were harvested by filtration and washed once with 50 ml of ice-cold nuclear isolation buffer (NIB; 50 mM MOPS pH 7.2, 150 mM KAc, 2 mM MgCl~2~) with 0.1% sodium azide, then washed again with 50 ml of NIB alone. Cell pellets were frozen at −70°C. Genomic DNA was purified from cells as described previously ([@B34]). Approximately 15 μg of genomic DNA was digested with 80 units of restriction enzymes (HindIII and KpnI) in a 200 μl reaction for 2.5 h at 37°C followed by ethanol precipitation. In the first dimension, DNA was run on a 0.4% agarose gel in the absence of ethidium bromide in TBE, for 24 h at 1 V/cm at room temperature. The second dimension was run at 4°C in TBE buffer (containing 0.3 μg/ml ethidium bromide circulating at 50--100 ml/min) at 6 V/cm, until the arc of linears had migrated 8--10 cm. DNA was transferred to a membrane using standard Southern blotting. Hybridizations were carried out at 68°C with ∼2 × 10^6^ c.p.m. of randomly primed probe. After washing, the membranes were exposed to BioMax film (Kodak).

Pulsed-field gel electrophoresis
--------------------------------

For analysis of whole chromosomes agarose plugs were prepared from mid log phase cells as described previously ([@B35]). Plugs were loaded in 0.8% pulsed-field certified grade agarose gels (Biorad) and electrophoresed at 14°C in a CHEF-DR III pulsed-field gel apparatus (Biorad) at 2 V/cm for 72 h, using three blocks. Parameters were: Block 1; switch time 1200 s, 96° included angle, run time 24 h; Block 2; switch time 1500 s, 100° included angle, run time 24 h and Block 3; switch time 1800 s, 106° included angle, run time 24 h.

For the Sfi1 restriction enzyme digest, the agarose plugs were pre-equilibrated for 30 min in NEB buffer 2 on ice (10 mM NaCl, 5 mM Tris-HCl pH 7.9, 1 mM MgCl~2~, 0.1 mM DTT, 100 μg/ml BSA). Buffer was then replaced, and 100 units of Sfi1 (NEB) added. The plugs were incubated overnight at 50°C and then washed twice for 30 min in TE10X on ice and then loaded onto a 1% pulsed-field certified grade agarose gel (Biorad) in 0.5 × TBE. Electrophoresis was performed at 14°C at 6 V/cm for 24 h, using one block with a switch time of 60--120 s and a 120° angle.

All gels were stained with ethidium bromide and visualized using a Dual Intensity Transilluminator. DNA was transferred to a membrane using standard Southern blotting. Hybridizations were carried out at 68°C with ∼2 × 10^6^ c.p.m. of randomly primed probe. After washing, the membranes were exposed to BioMax film (Kodak).

RESULTS
=======

Cdc18 stabilization leads to a Rad3-dependent mitotic block in the absence of re-replication
--------------------------------------------------------------------------------------------

To identify genes that play a role in the S-M checkpoint control, we screened for cDNAs which when overexpressed blocked onset of mitosis in a Rad3-dependent manner. For this screen ([Figure 1](#F1){ref-type="fig"}A), a *rad3^ts^* strain (CCL3) ([@B21]) was used where *rad3* is active at 25°C and inactive at 36°C. Clones were isolated that led to a cell cycle block and consequent cell elongation at 25°C but not 36°C ([Figure 1](#F1){ref-type="fig"}B). One clone contained a plasmid expressing the *cdc18* gene and retransformation confirmed that cell elongation was only induced at 25°C when *rad3* was active. Transformation into a wild type strain (CCL1) and a non-functional *rad3-136* strain (CCL6) confirmed that cell elongation was independent of temperature and dependent on Rad3.

Over-expression of Cdc18 to high levels induces re-replication resulting in giant nuclei and increased DNA ([@B35]). Overexpression of the C-terminus of Cdc18 also induces re-replication and a Rad3-dependent block of mitosis, whilst overexpression of the Cdc18 N-terminus induces a Rad3-independent block of mitosis but is unable to induce re-replication. The effect of the Cdc18 N-terminus is thought to be the result of a non-physiological interaction with Cdc2 (see [Table 2](#T2){ref-type="table"}) ([@B36]). No re-replication was observed with the newly isolated plasmid as assessed by FACS, which was compared with the FACS profile of pRep3X *cdc18*-induced re-replication ([Figure 1](#F1){ref-type="fig"}C, D). Possible explanations for the lack of re-replication were that the cDNA was 16 base pairs shorter in the 5′-untranslated region (5′UTR) compared with the previously studied re-replication-inducing cDNA, or that the pRep4X vector was used rather than pRep3X. In support of the 5′UTR having an effect, re-replication was also not observed with the original *cdc18* cDNA isolate, which lacks the 5′UTR ([@B32]). We speculated that this moderate level of Cdc18 overexpression might induce the S-M checkpoint without re-replication, and to investigate this further sought to increase Cdc18 level in a more controlled manner by modifying Cdc18 stability. Table 2.The variation in effects seen with different Cdc18 constructsConstructEffectsRe-replicationMitotic blockRad3-dependent blockTransient blockChanges in size/variability chromosome III**pRep3X *cdc18***YesYesNoNoNot known(Nishitani and Nurse, 1995)**pRep3X C-terminus *cdc18***YesYesYesNoNot known(Greenwood *et al*., 1998)**pRep3X N-terminus *cdc18***NoYesNoNoNot known(Greenwood *et al*., 1998)**pRep4X *cdc18***NoYesYesNoNot known(This article)***cdc18-T6A***NoYesYesYesYes(This article)

Phosphorylation of the 6 CDK consensus sites by Cdc2 regulates the stability of the Cdc18 protein ([@B31],[@B33],[@B37; @B38; @B39]) and over-expression of a mutant lacking these phosphorylation sites (Cdc18-T6A) results in increased re-replication ([@B38]). We replaced the endogenous *cdc18* gene in a *rad3^ts^* strain by a *cdc18-T6A* mutant gene encoding a protein with all 6 CDK sites mutated to alanine expressed by the endogenous *cdc18* promoter (see Materials and Methods section for strain construction). Incubation of this strain (CCL9) at 25°C resulted in cell elongation ([Figure 2](#F2){ref-type="fig"}A), but not at 36°C. No re-replication was observed by FACS, no enlarged nuclei were observed ([Figure 2](#F2){ref-type="fig"}A--C), and no replication intermediates were detected by 2D neutral/neutral gel electrophoresis when the *cdc18-T6A* strain was arrested at the G2/M transition in a *cdc25-22* mutant background (CCL13) ([Figure 2](#F2){ref-type="fig"}D). This result contrasts to that obtained when Cdc18 was overexpressed from pRep3X in a G2 block; in these cells 2D gel electrophoresis clearly demonstrated the presence of replication intermediates ([@B32]). Figure 2.Stabilization of Cdc18 levels by mutation of the CDK consensus sites induces a Rad3-dependent cell cycle arrest in the absence of replication forks. (**A**) Top panel: a *rad3^ts^* strain (CCL9) expressing the *cdc18-T6A* mutant from the endogenous locus was constructed and grown on plates in minimal medium at 36 or 25°C. Bottom panel: cells from a liquid culture of the same strain grown at 36°C and then shifted at 25°C for 6 h were fixed and stained with DAPI. (**B**) FACS analysis was performed on the same samples and corresponding control strains (CCL1, CCL3) as indicated. (**C**) *Cdc25-22* cells were grown overnight at 25°C before shifting to 36.5°C to use as a control for length and FACS. Samples were taken every 2 h for the next 10 h for FACS analysis and DAPI staining. Elongated cells after 2 h in the G2 block are shown to demonstrate equivalent nuclear staining at an equivalent length to CCL9. Note the FACS after 2 h in the G2 block is also equivalent to that seen in the presence of the Cdc18-T6A mutant protein. (**D**) 2D-gel of genomic DNA extracted from *cdc25-22 rad3*Δ*ura4 Cdc18-T6A* (CCL13) was probed for *ars3001*. This strain behaves as wild-type *cdc25^+^* at the permissive temperature of 25°C, but as *cdc25*^−^ at the restrictive temperature of 36.5°C. Samples were collected from cycling cells at 25°C (left) or from G2 arrested cells after incubation for 3 h at 36.5°C (right). Note absence of replicating structures in the G2 arrested culture.

Western blotting of Cdc18 in the pRep3X *cdc18*, pRep4X *cdc18, cdc18-T6A* and wild type strains demonstrated that re-replication occurred at higher levels of Cdc18 as described previously ([@B33]), whilst Rad3-dependent arrest in the absence of apparent re-replication occurred at lower levels of Cdc18 (pRep4X *cdc18* and *cdc18-T6A*) ([Figure 3](#F3){ref-type="fig"}). We conclude that moderately elevated levels of Cdc18, either by overexpression of wild-type Cdc18 or by stabilization of mutant Cdc18-T6A protein levels leads to a Rad3-dependent mitotic block in the apparent absence of re-replication. Figure 3.Different effects may relate to different levels of Cdc18 overexpression. Wild type (*rad3^+^*) cells, wild type (*rad3^+^*) cells containing pRep3X *cdc18*, and *rad3^ts^* cells containing pRep4X *cdc18*, were cultured for 24 h in the presence (OFF) or in the absence (ON) of thiamine. Wild type (*rad3^+^)* and *rad3^ts^ cdc18-T6A* cells were also cultured for 24 h. Total protein lysates were separated on 10% SDS-PAGE and blotted on nitrocellulose membrane. The membrane was probed with polyclonal anti-Cdc18 antibodies ([@B32]). Note that the Cdc18-T6A band is higher in the gel than wild-type Cdc18 due to presence of the TAP tag. Note all lanes are from the same gel, separated to distinguish the slower running TAP-tagged Cdc18-T6A from wild Cdc18.

To investigate activation of the Rad3-dependent checkpoint in the presence of moderately elevated levels of Cdc18, we used a *rad3^ts^ cdc18-T6A* (CCL9) mutant to follow the dynamics of the Rad3-dependent cell cycle block. Colonies growing at 36°C were replica-plated to 25°C. After 5 h at 25°C widespread cell elongation was seen, although by 24 h the cells had reverted to a wild-type length. Cell elongation was investigated further by shifting liquid culture populations of both *rad3^ts^ cdc18-T6A* (CCL9) and control *rad3^ts^* (CCL3) cells from 36 to 25°C, in order to impose the Cdc18-induced Rad3-dependent block, and following them for 7 h. After 7 h at 25°C, mutant *cdc18-T6A* septated cells were found to be 60% longer than wild-type septated cells (22.8 μm versus 13.9 μm); there were no differences in length at division at *t* = 0 h. We conclude that the *cdc18-T6A* mutant leads to cell elongation and G2 delay.

Cdc18 sends the checkpoint signal via Rad3/Chk1/Crb2
----------------------------------------------------

The above results indicate that the elevated level of Cdc18 seen in the *cdc18-T6A* mutant may be sending an S-M checkpoint signal in the absence of DNA replication intermediates. If correct, *rad3* inactivation would abrogate the signal and release the cells from the cell cycle block. To test this, an asynchronous population of *rad3^ts^ cdc18-T6A* (CCL9) cells was blocked for 4 h at 25°C. The temperature was then raised to 36°C for 1 h to inactivate *rad3* (see schematic in [Figure 4](#F4){ref-type="fig"}A). As predicted, cells were synchronously released from the cell cycle block and underwent a normal mitosis in the absence of Rad3 ([Figure 4](#F4){ref-type="fig"}A). This experiment demonstrated that Rad3 is required both to initiate and to maintain the checkpoint signal generated by the elevated level of Cdc18 in the *cdc18-T6A* mutant. Figure 4.Mutation of the CDK consensus of Cdc18 results in Rad3-dependent cell cycle arrest and Chk1 activation. (**A**) A *rad3^ts^ cdc18-T6A* (CCL9) strain was incubated for 4 h at 25°C to block cells at the G2-M transition. Cells were released by shifting the culture for 3 h to 36°C (schematic). From the time of the shift to 36°C, samples were taken every 20 min and cell cycle progression followed by FACS analysis (bottom right). The percentage of binucleated cells and the septation index were determined (bottom left). (**B**) *A rad3^ts^ cdc18-T6A chk1-HA* (CCL12) culture was synchronized and released as in A, but shifted back to 25°C after 1 h to re-impose the mitotic block. Total protein lysates, from samples taken every 20 min from release, were prepared and separated by SDS-PAGE followed by western blotting using anti-HA antibodies. (**C**) Strains CCL15-24 confirmed that the Cdc18-activated Rad3-dependent cell cycle arrest acts through the Chk1/Crb2 pathway, and not Cds1/Mrc1. Wild-type growth of the *cdc18-T6A* mutant was seen in the absence of all the Rad checkpoint proteins, and of Chk1 and Crb2. However, elongation was observed in the absence of Cds1 and Mrc1. *Rad3*Δ:*:ura4^+^ cdc18-T6A* (CCL14), which grows normally at all temperatures, was used as a control.

A synchronous culture of *rad3^ts^ cdc18-T6A chk1-HA* (CCL12) was then used to test for activation of the downstream effector checkpoint kinases Cds1 and Chk1. After *rad3* inactivation for 1 h at 36°C (see schematic in [Figure 4](#F4){ref-type="fig"}B), the culture was shifted back to 25°C for 2 h to re-impose the mitotic block. Protein extract samples were taken every 20 min and the phosphorylation status of Cds1 and Chk1 analysed by western blot. After shift back to 25°C when *rad3* was active, only a small proportion of the Cds1 protein pool showed the altered mobility indicative of its phosphorylated active form ([@B14]) (data not shown). However, most of Chk1 was converted to a slow migrating form corresponding with its phosphorylation and activation ([@B39]) ([Figure 4](#F4){ref-type="fig"}B), suggesting that Chk1 is likely to be the main effector kinase responsible for the block. Strains were constructed to test whether Chk1 and the other checkpoint proteins were required for the block (CCL15-24). The *rad3^ts^ cdc18-T6A* (CCL9) strain was crossed with *chk1*Δ, *cds1*Δ, *chk1*Δ*cds1*Δ, *rad9*Δ, *hus1*Δ, *rad17*Δ, *rad1*Δ, *rad26*Δ, *crb2*Δ and *mrc1*Δ strains in a *leu1-32* background. Several *leu^+^ kan^r^* (also *ura^+^* for *chk1*Δ*cds1*Δ) isolates of *cdc18-T6A* in all checkpoint mutant backgrounds were selected by random spore analysis. These were *rad3^+^* or *rad3^ts^*, except *for cdc18-T6A cds1*Δ and *cdc18-T6A mrc1*Δ, which were only obtained in a *rad3^ts^* background. This result suggested that the Cdc18-T6A-induced checkpoint could only be activated in a *cds1*Δ or *mrc1*Δ background. To confirm this, the *rad3^ts^* isolates for all the checkpoint mutants were plated at 36°C to inactivate *rad3* and left to form colonies (72 h). The colonies were then replica-plated and incubated at 25°C before screening for cell elongation at 6 and 24 h. Normal wild type looking cells were seen in *chk1, chk1cds1, rad9, hus1, rad17, rad1, rad26* and *crb2* deletion mutants showing that the checkpoint could not be activated in these mutant strains. In contrast, the absence of either Cds1 or its activating partner Mrc1 had no effect on the ability of Cdc18-T6A to activate the checkpoint and the cells became elongated ([Figure 4](#F4){ref-type="fig"}C). We suggest that an elevated level of Cdc18-T6A activates the checkpoint through the Chk1 kinase, that components of the Rad checkpoint protein network such as Rad3 are required for the cell cycle block, and that Cds1 and Mrc1 are not required for the Cdc18-induced checkpoint.

Cdc18-T6A causes changes in the size of chromosome III
------------------------------------------------------

Because Chk1 is the main effector kinase for the DNA damage checkpoint, we investigated whether the Cdc18-T6A protein was acting through either induced DNA damage or effects on S phase. The Cdc18-T6A mutant protein had no detectable effect on exponential cell growth, with the generation time for both control and mutant strains at 36°C being 165 minutes (calculated from logarithmic plots of cell number measurements). To determine its effects on S phase, synchronized cultures of both mutant (CCL13) and wild-type *cdc18* (CCL8) in a *rad3*Δ::*ura4^+^* background were prepared using a *cdc25-22* block and release procedure. No differences were observed in the timing of S phase initiation and completion, as seen on FACS analysis ([Figure 5](#F5){ref-type="fig"}A) and with cell number and septation index measurements ([Figure 5](#F5){ref-type="fig"}B), although the mutant protein was present at an elevated level during S phase and, in contrast to wild type, remained present throughout G2 ([Figure 5](#F5){ref-type="fig"}C). Next, a mutagenesis assay was performed to see if there was any increase in the forward mutation rate (FMR) of *ura4^+^* to *ura4*^−^ ([@B40]) in the presence of the Cdc18-T6A mutant protein. *Rad3^ts^ura4^+^* (CCL4) and *rad3^ts^ura4^+^cdc18-T6A* (CCL10) strains were grown to mid log phase and plated out onto YE5S media containing 5FOA for 3 days at 36°C. The FMR per 10^7^ cells was 3.6 for *rad3^ts^ura4^+^* and 2.8 for *rad3^ts^ura4^+^cdc18-T6A* indicating that the elevated levels of Cdc18 in the *cdc18-T6A* mutant do not significantly affect the spontaneous mutation rate. Figure 5.Mutation of the CDK consensus of Cdc18 does not affect S phase entry or duration. (**A**) A *cdc25-22 rad3*Δ:*:ura4^+^ cdc18-TAP* (CCL8) and a *cdc25-22 rad3*Δ:*:ura4^+^ cdc18-T6A-TAP* (CCL13) strains were synchronized in late G2 by a 4 h incubation at 36°C. After release to the permissive temperature of 25°C, samples were taken every 20 min and cell cycle progression was followed by flow cytometry analysis. (**B**) Samples were also taken every hour from the start of the G2 arrest at 36°C for measurement of cell number (left panel) and every 20 min from release for measurement of septation index. (**C**) Total protein lysates from samples from A were prepared and separated by SDS-PAGE followed by western blotting using the PAP antibody or anti-tubulin. AS = asynchronous population.

A pulsed-field gel electrophoresis (PFGE) analysis of *cdc18-T6A* cells was performed to determine if the mutant Cdc18 protein had any effect on chromosome mobility. Unexpectedly, in the presence of Cdc18-T6A, chromosome III (Chr III) was not visualized with ethidium bromide staining in either cycling (CCL9) or G2 arrested (CCL13) cells ([Figure 6](#F6){ref-type="fig"}A), despite the normal appearance and behaviour of chromosomes I and II. Southern blotting and probing for chromosome III with both non-origin rDNA and ade6 revealed chromosome III present in the gel as a smear upwards from 3.5 to 7 Mb ([Figure 6](#F6){ref-type="fig"}B). Chromosome III behaved normally in the *rad3^ts^* (CCL3) and *rad3*Δ*cdc25-22* (CCL7) control strains. Synchronized cultures of mutant *cdc18-T6A* in a *rad3*Δ background (CCL13) were prepared using the *cdc25-22* block and release procedure described above to determine if the chromosome III behaviour changed during the cell cycle. General chromosomal gel entry was reduced as expected during S phase due to the presence of replication intermediates, but chromosome III was not visualized with ethidium bromide staining at any point in the cell cycle ([Figure 6](#F6){ref-type="fig"}C). Southern blotting and probing for chromosome III with non-origin rDNA revealed a smear throughout the cell cycle ([Figure 6](#F6){ref-type="fig"}C). Figure 6.The Cdc18 phosphorylation mutant affects the mobility of chromosome III the cell cycle. (**A**) Chromosome III not visualized in the presence of Cdc18-T6A on ethidium bromide staining, either in asynchronous cycling cells (CCL9) (left panel) or G2 arrested cells (CCL13) (right panel), but is present in the corresponding controls (CCL3 and CCL7). (**B**) Southern blotting and probing with non-origin rDNA (for a fragment downstream of *ars3001*) (top panel) and *ade6* (bottom panel) demonstrate chromosome III is present in the gel as a smear. (**C**) *Cdc25-22 rad3*Δ:*:ura4^+^ cdc18-T6A* cells (CCL13) were synchronized in G2 by growing overnight at 25°C and then shifting to 36.5°C for 3.5 h. Cells were then released by shifting back to 25°C and samples taken for septation index (top panel) and PFGE (middle panel) every 20 min for 3 h. The PFG was Southern blotted and probed with non-origin rDNA for chromosome III (bottom panel). CCL1 = wt.

We hypothesized that if it was the presence of Cdc18-T6A that changes the size of chromosome III, then elimination of Cdc18-T6A would allow stabilization of the size of chromosome III. The mutant *cdc18* gene was crossed out of a *cdc25-22 rad3*Δ *cdc18-T6A* strain (CCL13) (here, the *cdc18-T6A* strain is TAP tagged and marked with the *kan^r^* gene, this confers G418 resistance and was used to follow presence of the *cdc18-T6A* gene) and *wild type, rad3Δ* and *cdc25-22 rad3*Δ strains were selected by random spore analysis. Cycling cells from these strains were analysed by PFGE ([Figure 7](#F7){ref-type="fig"}A) followed by Southern blotting and rDNA probing ([Figure 7](#F7){ref-type="fig"}B). In 17 strains analysed (not all data shown), chromosome III was now found to form a discrete band with an approximate 1:1 split between a normal sized chromosome III (in 9 out of the 17) and increased (up to 7 Mb) sized chromosome III (in 8 out of the 17). We selected 4 of these strains (2 with a large chromosome III, and 2 with a normal-sized chromosome III) for further analysis. Each strain was cultured both overnight and for 30 generations before processing the cells for PFGE. Southern blotting and rDNA probing demonstrated that after 30 generations of growth, the normal-sized chromosome IIIs remained unchanged, but in contrast the larger chromosome IIIs returned closer to a normal size ([Figure 7](#F7){ref-type="fig"}C). In strains derived from the cross that still contained the *cdc18-T6A* mutant, chromosome III remained smeared as in the parent strain (data not shown). Thus, we conclude that the Cdc18 phosphorylation mutant protein induces changes in the size of chromosome III. These changes disappear with removal of the mutant Cdc18. It is therefore unlikely that an additional unknown mutation is producing the size variability of chromosome III. Figure 7.The changes in the size and variability of chromosome III disappear with removal of the Cdc18 phosphorylation mutant. (**A**) Ethidium bromide stained PFG of cross-derived strains not containing *cdc18-T6A*: 1--4 *rad3^+^ cdc25^+^* isolates; 5--7 *rad3*Δ *cdc25^+^* isolates; 8--10 *rad3^+^ cdc25-22* isolates; 11,12 *rad3*Δ *cdc25-22* isolates. (**B**) Southern blotting and probing of A for chromosome III with non-origin rDNA. (**C**) Southern blotting and probing for chromosome III with non-origin rDNA in four of the strains from A. Top panel: overnight culture before chromosomal agarose plug preparation. Bottom panel: 30 generation culture before chromosomal agarose plug preparation. CCL1 = wt.

Chromosome III contains rDNA repeats found in 915 Kb (containing 73% of the repeats) and a 242 Kb (containing 27% of the repeats) Sfi1 fragments. To determine if changes occurred in this region, an Sfi1 digest of chromosomes derived from the *cdc18-T6A* strain (CCL9) in agarose plugs was performed. PFGE was carried out under different conditions, first to resolve smaller fragments (in the Kb range), and then to resolve larger fragments (in the Mb range). This was followed by Southern blotting and probing for chromosome III with non-origin rDNA. Probing for rDNA in the first run ([Figure 8](#F8){ref-type="fig"}A) showed the loss of both rDNA containing bands, and the second run ([Figure 8](#F8){ref-type="fig"}B) clearly demonstrated a smear extending from 915 Kb up to the 2 Mb region of the gel. We conclude that there is expansion in the restriction fragments containing the rDNA repeats within chromosome III in the presence of the Cdc18-T6A phosphorylation mutant protein. Figure 8.There is an expansion in the restriction fragments containing the rDNA repeats within chromosome III in the presence of Cdc18-T6A. (**A**) Agarose plugs containing chromosomes with wild-type *cdc18* from the *rad3^ts^* strain (CCL3), and with *cdc18-T6A* in the *rad3^ts^* background (CCL9), underwent Sfi1 digest prior to PFGE under conditions to resolve fragments in kilobase (Kb) range. Southern blotting of and probing for chromosome III with non-origin rDNA followed. (**B**) As in A except PFGE was run under conditions to resolve fragments in megabase (Mb) range. CCL3 = wt.

The rDNA repeat organization strongly influences the organization and localization of the nucleolus ([@B41]). We used a GFP-tagged nucleolar protein Gar2 (CCL25), which localizes to the rDNA, to further investigate the observed changes in chromosome III ([@B42]). The cells' DNA was also DAPI stained to demonstrate the nucleus. In wild-type cells (CCL26), Gar2-GFP occupied a discrete region, distinct from the bulk chromosomal DNA ([Figure 9](#F9){ref-type="fig"}A). Abnormalities were observed in 150 of 200 *cdc18-T6A* mutant cells (75%), including enlarged staining and fragmentation (see arrows in [Figure 9](#F9){ref-type="fig"}A). These abnormalities were not observed in the wild type strain and suggest that in the presence of Cdc18-T6A there are changes in the nucleolar structure. Figure 9.Cdc18-T6A induces inappropriate recombination in the rDNA repeats. (**A**) Gar2-GFP and Gar2-GFP Cdc18-T6A were observed in live cells using fluorescence microscopy. Arrows indicate abnormal nucleolar structures. Note: top panel Gar2-GFP only; bottom panel co-staining with Gar2-GFP and DAPI. (**B**) Left panel: strains with the indicated background (all containing the *rad3^ts^* allele) were grown at 36°C and shifted to 25°C for 6 h. Right panel: the percentage of cells (200 observed per strain) elongated greater than twice wild-type length.

rDNA recombination influences *cdc18-T6A* cell elongation
---------------------------------------------------------

Cdc18-T6A may activate the checkpoint by stimulating recombination within the rDNA repeats, leading to changes in copy number of the repeats. To see whether recombination was involved in activating the Cdc18-T6A-induced checkpoint, we tested several different situations where recombination frequency in the rDNA repeats was altered. In budding yeast, *rad52* is necessary for homologous recombination ([@B43]), and so we looked for the effects of deleting its *S. pombe* homologue, *rad22*, on the Rad3-dependent elongation of the *cdc18-T6A* mutant strain (CCL11) ([Figure 9](#F9){ref-type="fig"}B). We found that there was less elongation of the *cdc18-T6A* mutant strain in the *rad22*Δ background ([Figure 9](#F9){ref-type="fig"}B), suggesting that the absence of recombination partially suppresses the *cdc18-T6A* elongated phenotype.

Polar replication fork barriers (RBF) are a conserved feature of rDNA in eukaryotes, and rDNA copy number is maintained through recombination events associated with RBF ([@B44],[@B45]). We speculated that inactivation of the RBF would suppress recombination in the rDNA repeats, and prevent activation of the Cdc18-T6A-induced checkpoint. *S. pombe* rDNA contains three RBFs (RBF1, 2 and 3) and the termination protein Reb1 is required for arrest of replication forks at RBF2 and RBF3, but not RFB1 ([@B45]). We found that deletion of *reb1* reduced the extent of cell elongation seen with the *cdc18-T6A* mutant strain (CCL5) ([Figure 9](#F9){ref-type="fig"}B). This result suggests that the failure to stall replication forks at the RFB2 and RFB3 sites within the rDNA repeats has an affect on the ability of Cdc18-T6A to delay entry into mitosis.

The Rqh1 helicase suppresses inappropriate recombination in fission yeast ([@B46]), and *rqh1* deletion leads to considerable variation in the size of chromosome III ([@B44]). After deletion of *rqh1*, a *rad3*^−^ *cdc18-T6A* strain was not viable, raising the possibility that Cdc18 is driving recombination events, which are lethal in the absence of the Rqh1 helicase. We suggest that recombination is contributing in part to the Cdc18-T6A-induced Rad3-dependent G2 delay, and that reducing rDNA recombination or the cause of recombination (that is replication fork stalling), partially relieves the G2 delay.

DISCUSSION
==========

Our results have shown that the *cdc18* phosphorylation mutant, *cdc18-T6A*, has moderately elevated levels of Cdc18 compared to a wild type strain. The presence of Cdc18-T6A leads to a transient activation of a Rad3-dependent checkpoint, blocking the onset of mitosis in the absence of detectable replication intermediates or DNA over replication. We found that moderately overexpressed wild-type Cdc18 also acts upstream of Rad3 in the checkpoint pathway to block the onset of mitosis. Cdc18-T6A acts via Rad3 to bring about Chk1 phosphorylation and activation, and the Rad checkpoint protein network is necessary for this cell cycle block. In contrast, Cds1 and Mrc1 are not required for the cell cycle block. In the absence of Rad3, the *cdc18-T6A* cells containing elevated Cdc18 protein levels have the same generation time as those containing wild-type Cdc18, there is no difference in the timing of S phase initiation and completion, and there are no gross effects on mutation rate. We conclude that the increased level of Cdc18 transiently activates the Rad3-dependent checkpoint through Chk1, with no other obvious effects on the cell cycle. However, one unexpected consequence of an elevated Cdc18 level in the *cdc18-T6A* mutant was an increase in the size of chromosome III, with expansion of Sfi1 restriction fragments, which contain rDNA repeats and with differences in the nucleolar structure, which contains the rDNA repeats.

Cdc18 may be inducing genome wide replication at a low level, which is not detectable by FACS analysis or by 2D DNA gels. In the regions containing the rDNA repeats on chromosome III, the presence of a low level of replication bubbles could increase recombination and unequal cross-over events leading to an increase in size of the rDNA containing restriction fragment. We found that decreasing recombination, either by deleting *rad22* or inactivation of the RFB, partially suppressed the cell elongation phenotype normally seen with the *cdc18-T6A* mutant, whilst increasing recombination, by deletion of *rqh1* in a *cdc18-T6A* mutant, causes cell death suggesting that high levels of recombination are lethal. These data suggest that recombination plays some role in activating the checkpoint. However, the reduction in recombination did not completely abolish checkpoint activation. This may be because some recombination still occurs in the mutants tested, or that Cdc18-T6A also activates the checkpoint independently of the effects on chromosome III.

It is possible that the effect on rDNA repeat number due to the increased level of Cdc18 in the *cdc18-T6A* mutant may act through a mechanism involving cohesin. Proper sister chromatid cohesion enables DSB repair by recombination without any net change in the number of rDNA. Sister chromatids are held together by cohesin, a multi-subunit protein complex, from their synthesis in S phase until anaphase segregation. Cohesin loading in *Xenopus* has been shown to be dependent on the formation of the pre-replicative complex: Cdt1, MCM2-7, ORC and CDC6 ([@B47]). The Sir2 histone deacetylase required for heterochromatin formation acts to silence the rDNA locus, and is a negative regulator of DNA replication in budding yeast ([@B48]) suppressing rDNA copy number changes via effects on cohesin association. Cohesin dissociation leads to sister chromatid misalignment and subsequent upward expansion of the rDNA repeats ([@B49]). Therefore, in our experiments the increased levels of Cdc18 present after S phase in the *cdc18-T6A* mutant could interfere with cohesin association leading to mis-alignment and upward rDNA expansion.

It has also been shown in *Saccharomyces cerevisiae* that perturbations in origin firing lead to lesions in the DNA, especially within the rDNA ([@B50]). PFGE revealed high chromosome XII instability in ORC mutants, and the monitoring of abnormal initiation was found to be rDNA copy number-dependent. These findings led to the suggestion that the rDNA locus plays an important DNA damage surveillance role during the initiation of DNA replication.

Although the cell cycle delay seen is likely to be due at least in part to the observed changes in chromosome III, we cannot exclude that Cdc18 has more than one effect and that the elevated level of Cdc18 may also directly activate the cell cycle checkpoint. With this model, activation of the Rad3/Chk1 dependent S-M block would be a direct consequence of elevated Cdc18, and is not due to effects on DNA replication, recombination or damage. Consistent with this view is the fact that cells containing Cdc18-T6A and lacking Rad3 appear to grow normally which would not be the case if damaging changes were occurring to the DNA. It may also be that the Cdc18-T6A mutant protein has other effects independent of Cdc18 stabilization because the protein cannot be phosphorylated.

The replication origin *ars3001* has been mapped to a 600 bp region within the non-transcribed spacer region of the ribosomal DNA (rDNA) repeats upstream of the rDNA genes. It has been confirmed that origin activity is restricted to this sequence, and is not detected in other regions of the 10.9 Kb rDNA repeat. This is the most abundant origin in the *S. pombe* genome, and hence chosen for the 2D DNA gels performed ([@B51],[@B52]). The same probe was used as to identify the rDNA as a marker of the presence of chromosome III. As the changes in chromosome III appear to localize to the rDNA and low level replication leading to recombination is a possible cause of these changes, the fact that the *ars3001* origin probe did not pick up any replication intermediates in the presence of Cdc18-T6A in G2 arrested cells suggests that any ongoing replication is very low-level indeed.

We have shown that a moderately elevated level of Cdc18, generated either by ectopic expression or by modifying Cdc18 stability, activates the Rad3-dependent checkpoint. We propose that this is the result of a low level of Cdc18-induced replication causing subsequent recombination and expansion of the rDNA repeat regions on chromosome III, but suggest other possibilities such as ectopic checkpoint activation in the absence of any replication or a Cdc18-T6A-specific effect on chromosome III.
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